Precision SGLT2 Inhibitor Strategies for Cardiovascular and Renal Outcomes in Type 2 Diabetes
Cardiovascular and renal complications remained the leading causes of morbidity and mortality in type 2 diabetes, affecting approximately 537 million adults globally in 2021 with projections exceeding 783 million by 2045. Sodium-glucose cotransporter-2 (SGLT2) inhibitors transformed diabetes management by demonstrating...